Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
NCT00181532Phase 2Completed
- Sponsor
- Maastro Clinic
- Start
- May 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in non-small cell lung cancer (NSCLC), sponsored by Maastro Clinic. Started May 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00181532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181532.